Institute of Neuroscience, Université catholique de Louvain (UCLouvain), 1200 Brussels, Belgium; Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), 1200 Brussels, Belgium; WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Cell Rep. 2020 Oct 13;33(2):108238. doi: 10.1016/j.celrep.2020.108238.
Patients with alcohol use disorder (AUD) present with important emotional, cognitive, and social impairments. The gut microbiota has been recently shown to regulate brain functions and behavior but convincing evidence of its role in AUD is lacking. Here, we show that gut dysbiosis is associated with metabolic alterations that affect behavioral (depression, sociability) and neurobiological (myelination, neurotransmission, inflammation) processes involved in alcohol addiction. By transplanting the gut microbiota from AUD patients to mice, we point out that the production of ethanol by specific bacterial genera and the reduction of lipolysis are associated with a lower hepatic synthesis of β-hydroxybutyrate (BHB), which thereby prevents the neuroprotective effect of BHB. We confirm these results in detoxified AUD patients, in which we observe a persisting ethanol production in the feces as well as correlations among low plasma BHB levels and social impairments, depression, or brain white matter alterations.
患有酒精使用障碍(AUD)的患者表现出重要的情绪、认知和社交障碍。肠道微生物群最近被证明可以调节大脑功能和行为,但缺乏其在 AUD 中作用的确凿证据。在这里,我们表明肠道菌群失调与代谢改变有关,这些改变会影响涉及酒精成瘾的行为(抑郁、社交能力)和神经生物学(髓鞘形成、神经递质传递、炎症)过程。通过将 AUD 患者的肠道微生物群移植到小鼠中,我们指出特定细菌属产生乙醇和脂肪分解减少与肝内合成β-羟基丁酸(BHB)减少有关,从而阻止了 BHB 的神经保护作用。我们在经过解毒的 AUD 患者中证实了这些结果,在这些患者中,我们观察到粪便中持续产生乙醇,以及低血浆 BHB 水平与社交障碍、抑郁或大脑白质改变之间存在相关性。